![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZzhHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1a1e60a5f96c2eda5b410d2c36deb331f8f8a115/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Agomab.png)
Agomab Therapeutics
Agomab is a biotech company developing novel treatments that aim to preserve and restore organ function in fibrotic diseases.
Agomab is a biotech company developing novel treatments that aim to preserve and restore organ function in fibrotic diseases.